TIM
SRPT icon

Thornburg Investment Management’s Sarepta Therapeutics SRPT Stock Holding History

Thornburg Investment Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-9,458
Closed -$6.04M – 187
2025
Q1 		$6.04M Sell
9,458
-29,526
-76% -$3.11M 0.01% 174
2024
Q4 		$4.74M Sell
38,984
-475
-1% -$58.2K 0.06% 142
2024
Q3 		$4.93M Sell
39,459
-723
-2% -$99.9K 0.06% 150
2024
Q2 		$6.35M Buy
40,182
+3,911
+11% +$502K 0.09% 140
2024
Q1 		$4.7M Sell
36,271
-4,074
-10% -$499K 0.07% 158
2023
Q4 		$3.89M Buy
40,345
+23,406
+138% +$2.25M 0.06% 155
2023
Q3 		$2.05M Buy
+16,939
New +$1.91M 0.03% 165

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Thornburg Investment Management's SRPT Position: Q2 2025 in Review

Thornburg Investment Management sold out of Sarepta Therapeutics (SRPT) in Q2 2025, closing a stake of 9,458 shares — an estimated $6.04M sold.

Thornburg Investment Management first reported a position in SRPT in Q3 2023 and held it in 7 quarters. The position peaked at $6.35M in Q2 2024. 363 funds tracked by Wall St. Rank hold SRPT as of Q2 2025.

  • Thornburg Investment Management reported no remaining Sarepta Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Thornburg Investment Management sold 9,458 Sarepta Therapeutics shares in Q2 2025, an estimated $6.04M.
  • Thornburg Investment Management first reported a position in Sarepta Therapeutics in Q3 2023 and held it in 7 quarters.
  • Thornburg Investment Management's Sarepta Therapeutics position peaked at $6.35M in Q2 2024.
  • 363 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2025.

Based on Thornburg Investment Management's 13F filing for Q2 2025, filed 13 Aug 2025.